New Lawsuit Alleges Actos Bladder Cancer: Adverse Events

Share Article

According to court documents, on April 25th, 2012, a West Virginia man, Donald Shingleton, filed a lawsuit in Louisiana Western District Court (case no. 6:2012cv01001) alleging he suffered bladder cancer after taking Actos for several years. Actos is a popular medication used to control Type 2 diabetes, manufactured by Takeda Pharmaceuticals. On December 29th, 2011, the Judicial Panel on Multidistrict Litigation (JPML) established an MDL (MDL 2299) for all federal claims alleging injury caused by Actos including approximately 150 cases. The new lawsuit is part of the MDL. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Actos severe adverse events. http://www.attorneyone.com/actos-lawsuit/

Actos severe adverse events threat

Actos severe adverse events threat

use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer

The media spotlight is often a double-edged sword. No one knows this better than Donald Shingleton who filed a lawsuit on Actos Problems. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on April 25th, 2012, a West Virginia man, Donald Shingleton, filed the lawsuit “Shingleton et al v. Takeda Pharmaceuticals America Inc et al” in Louisiana Western District Court (case no. 6:2012cv01001) alleging he suffered bladder cancer after taking Actos for several years. Actos is a popular medication used to control Type 2 diabetes, manufactured by Takeda Pharmaceuticals. Shingleton began taking Actos in 2005. He was diagnosed with bladder cancer and he alleges that because of his use of Actos over many years, he suffered severe, life-threatening injuries and fear of premature death.

Several Actos lawsuits have been filed in both state and federal courts and on December 29th, 2011, the Judicial Panel on Multidistrict Litigation (JPML) established an MDL (MDL 2299). U.S. District Judge Rebecca Doherty presides over approximately 150 cases. The new lawsuit is part of the MDL.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Actos severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Actos remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On June 15th, 2011, the U.S. FDA issued a safety announcement informing the public that “use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer”. In 2011, Authorities in France and Germany banned sales of the drug after extensive research.

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Actos at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/4/prweb9454670.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
1-877-230-7343
Email >
Follow us on
Visit website